GLP-1RAs increase risk for cholelithiasis and GERD but not other GI or biliary adverse events vs. placebo.

Anderson, Kelsey L, Joseph D Feuerstein, and ACP Journal Club Editorial Team at McMaster University. 2026. “GLP-1RAs Increase Risk for Cholelithiasis and GERD But Not Other GI or Biliary Adverse Events Vs. Placebo.”. Annals of Internal Medicine 179 (1): JC11.